Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil-Reference-Cited by-同舟云学术

Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil

Published:2023-07-16 Issue:3 Volume:54 Page:1745-1750
ISSN:1517-8382
Container-title:Brazilian Journal of Microbiology
language:en
Short-container-title:Braz J Microbiol

Author:

Correa Lucas Pinheiro^ORCID,da Costa Farias Fatyene,dos Santos Barile Katarine Antonia,Palmeira Maurício Koury,de Melo Amaral Carlos Eduardo

Publisher

Springer Science and Business Media LLC

Subject

Microbiology,Computer Networks and Communications,Hardware and Architecture,Software

Link

https://link.springer.com/content/pdf/10.1007/s42770-023-01067-2.pdf

Reference37 articles.

1. Futsch N, Mahieux R, Dutartre H (2017) HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment. Viruses 10(1):1. https://doi.org/10.3390/v10010001

2. González-Alcaide G, Ramos JM, Huamaní C, Mendoza C, Soriano V (2016) human t-lymphotropic virus 1 (htlv-1) and human t-lymphotropic virus 2 (htlv-2): geographical research trends and collaboration networks (1989-2012). Rev Inst Med Trop Sao Paulo 58:11. https://doi.org/10.1590/S1678-9946201658011

3. Martinez MP, Al-Saleem J, Green PL (2019) Comparative virology of HTLV-1 and HTLV-2. Retrovirology 16(1):21. https://doi.org/10.1186/s12977-019-0483-0

4. Schierhout G, McGregor S, Gessain A, Einsiedel L, Martinello M, Kaldor J (2020) Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis 20(1):133–143. https://doi.org/10.1016/S1473-3099(19)30402-5

5. Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ (2019) HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev Esp Quimioter 32(6):485–496